UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011272
Receipt number R000012654
Scientific Title Reliability and validity of Japanese version of Control Preferences Scale and Information Needs Questionnaire
Date of disclosure of the study information 2013/08/05
Last modified on 2021/03/26 14:15:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reliability and validity of Japanese version of Control Preferences Scale and Information Needs Questionnaire

Acronym

Reliability and validity of Japanese version of Control Preferences Scale and Information Needs Questionnaire

Scientific Title

Reliability and validity of Japanese version of Control Preferences Scale and Information Needs Questionnaire

Scientific Title:Acronym

Reliability and validity of Japanese version of Control Preferences Scale and Information Needs Questionnaire

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the reliability and validity of Control Preferences Scale and Information Needs Questionnaire.

Basic objectives2

Others

Basic objectives -Others

Psychometric property of Control Preferences Scale and Information Needs Questionnaire

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Psychometric property of Control Preferences Scale and Information Needs Questionnaire

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

1. Diagnosed as breast cancer.
2. Under chemotherapy or endocrine therapy more than 1 month from initiation of treatment.
3. Able to fill in the questionnaires by him/herself.

Key exclusion criteria

1. Cognitive disorder, agitation or delirium
2. Severe psychiatric disorder
3. Patients judged inappropriate for this study by the health care provider

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Takuhiro
Middle name
Last name Yamaguchi

Organization

Tohoku University Graduate School of Medicine

Division name

Division of Biostatistics

Zip code

980-8577

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, JAPAN

TEL

022-717-7659

Email

yamaguchi@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Kawaguchi

Organization

Tokyo University of Pharmacy and Life Sciences

Division name

Department of Practical Pharmacy

Zip code

192-0392

Address

192-0392, 1432-1 Horinouchi, Hachioji, Tokyo, Japan

TEL

042-676-1521

Homepage URL


Email

tkawa@toyaku.ac.jp


Sponsor or person

Institute

Tokyo University of Pharmacy and Life Sciences
Department of Practical Pharmacy

Institute

Department

Personal name



Funding Source

Organization

Tokyo University of Pharmacy and Life Sciences

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Breast Oncology, Tokyo Medical University Hospital
Department of Pharmacy, Tokyo Medical University Hospital
Nagumo Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical University Hospital

Address

6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023

Tel

03-3342-6111

Email

IRB@tokyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学病院(東京都)、ナグモクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2012 Year 11 Month 27 Day

Date of IRB

2012 Year 12 Month 26 Day

Anticipated trial start date

2013 Year 08 Month 05 Day

Last follow-up date

2013 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Making a comparison responses of the CPS and semi-structured interviews with patients.


Management information

Registered date

2013 Year 07 Month 25 Day

Last modified on

2021 Year 03 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012654


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name